NOD2-mediated innate immune signaling regulates the eicosanoids in atherosclerosis

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 33, Issue 9, 2013, Pages 2193-2201

  Liu, Hui Qing ^a,d   Zhang, Xiao Ying ^a,e   Edfeldt, Kristina ^a,b   Nijhuis, Manon Oude ^g   Idborg, Helena ^c   Bäck, Magnus ^a   Roy, Joy ^f   Hedin, Ulf ^f   Jakobsson, Per Johan ^c   Laman, Jon D ^h,i   De Kleijn, Dominique P ^g,j   Pasterkamp, Gerard ^g   Hansson, Göran K ^a   Yan, Zhong Qun ^a,f  

^a SCIENCE FOR LIFE LABORATORY   (Sweden)

^b Division of Translational Medicine and Chemical Biology   (United States)

^c KAROLINSKA INSTITUTE   (Sweden)

^d SHANDONG UNIVERSITY   (China)

^e PEKING UNIVERSITY HEALTH SCIENCE CENTER   (China)

^f KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^g UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^h ERASMUS MEDICAL CENTER   (Netherlands)

ⁱ NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^j ROYAL NETHERLANDS ACADEMY OF ARTS AND SCIENCES   (Netherlands)

more..

Author keywords

atherosclerosis; eicosanoids; immunity, innate; inflammation; pattern recognition receptors; peptidoglycan

Indexed keywords

ARACHIDONATE 15 LIPOXYGENASE; CASPASE RECRUITMENT DOMAIN PROTEIN 15; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; ICOSANOID; INTERLEUKIN 1BETA; LIPOXYGENASE; MESSENGER RNA; MURAMYL DIPEPTIDE; PROSTAGLANDIN E SYNTHASE 1; PROSTAGLANDIN E2; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CAROTID ATHEROSCLEROSIS; CONTROLLED STUDY; ENDOTHELIUM CELL; ENZYME ACTIVITY; EX VIVO STUDY; HUMAN; HUMAN CELL; HUMAN TISSUE; INNATE IMMUNITY; INTRACELLULAR SIGNALING; MACROPHAGE; PRIORITY JOURNAL; RECEPTOR DOWN REGULATION; UPREGULATION;

ATHEROSCLEROSIS; EICOSANOIDS; IMMUNITY, INNATE; INFLAMMATION; PATTERN RECOGNITION RECEPTORS; PEPTIDOGLYCAN;

ACETYLMURAMYL-ALANYL-ISOGLUTAMINE; ARACHIDONATE 12-LIPOXYGENASE; ARACHIDONATE 15-LIPOXYGENASE; ARACHIDONATE 5-LIPOXYGENASE; CAROTID ARTERIES; CAROTID ARTERY DISEASES; CASE-CONTROL STUDIES; CELLS, CULTURED; CYCLOOXYGENASE 2; DINOPROSTONE; EICOSANOIDS; ENDOTHELIAL CELLS; FIBROBLASTS; HUMANS; IMMUNITY, INNATE; INTERLEUKIN-1BETA; LIGANDS; NOD2 SIGNALING ADAPTOR PROTEIN; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PLAQUE, ATHEROSCLEROTIC; SIGNAL TRANSDUCTION; TIME FACTORS; TISSUE CULTURE TECHNIQUES; TRANSCRIPTION, GENETIC; TRANSCRIPTIONAL ACTIVATION; TUMOR NECROSIS FACTOR-ALPHA; UP-REGULATION;

EID: 84883304324     PISSN: 10795642     EISSN: 15244636     Source Type: Journal    
DOI: 10.1161/ATVBAHA.113.301715     Document Type: Article

References (45)

1. Yan ZQ, Hansson GK. Innate immunity, macrophage activation, and atherosclerosis. Immunol Rev. 2007;219:187-203. (Pubitemid 47390007)
2. Edfeldt K, Swedenborg J, Hansson GK, Yan ZQ. Expression of toll-like receptors in human atherosclerotic lesions: a possible pathway for plaque activation. Circulation. 2002;105:1158-1161. (Pubitemid 34225814)
3. Xu XH, Shah PK, Faure E, Equils O, Thomas L, Fishbein MC, Luthringer D, Xu XP, Rajavashisth TB, Yano J, Kaul S, Arditi M. Toll-like receptor-4 is expressed by macrophages in murine and human lipid-rich atherosclerotic plaques and upregulated by oxidized LDL. Circulation. 2001;104:3103-3108. (Pubitemid 34014065)
4. Kufer TA, Sansonetti PJ. NLR functions beyond pathogen recognition. Nat Immunol. 2011;12:121-128.
5. Girardin SE, Boneca IG, Viala J. Chamaillard M, Labigne A, Thomas G, Philpott DJ, Sansonetti PJ. Nod2 is a general sensor of peptidoglycan through muramyl dipeptide (mdp) detection J Biol Chem. 2003;278:8869-8872. (Pubitemid 36800360)
6. Inohara N, Ogura Y, Fontalba A, Gutierrez O, Pons F, Crespo J. Fukase K, Inamura S, Kusumoto S, Hashimoto M, Foster SJ, Moran AP, Fernandez-Luna JL, Nunez G. Host recognition of bacterial muramyl dipeptide mediated through nod2. Implications for crohn's disease. J Biol Chem. 2003;278:5509-5512. (Pubitemid 36800790)
7. Hasegawa M, Fujimoto Y, Lucas PC, Nakano H, Fukase K, Nunez G, Inohara N. A critical role of rick/rip2 polyubiquitination in nod-induced nf-kappab activation. EMBO J. 2008;27:373-383. (Pubitemid 351161652)
8. Sabbah A, Chang TH, Harnack R, Frohlich V, Tominaga K, Dube PH, Xiang Y, Bose S. Activation of innate immune antiviral responses by Nod2. Nat Immunol. 2009;10:1073-1080.
9. Ogura Y, Bonen DK, Inohara N, et al. A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease. Nature. 2001;411:603-606. (Pubitemid 32531409)
10. Hugot JP, Chamaillard M, Zouali H, et al. Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease. Nature. 2001;411:599-603. (Pubitemid 32531408)
11. Galluzzo S, Patti G, Dicuonzo G, Di Sciascio G, Tonini G, Ferraro E, Spoto C, Campanale R, Zoccoli A, Angeletti S. Association between NOD2/CARD15 polymorphisms and coronary artery disease: a case-control study. Hum Immunol. 2011;72:636-640.
12. Kwon MY, Liu X, Lee SJ, Kang YH, Choi AM, Lee KU, Perrella MA, Chung SW. Nucleotide-binding oligomerization domain protein 2 deficiency enhances neointimal formation in response to vascular injury. Arterioscler Thromb Vasc Biol. 2011;31:2441-2447.
13. Laman JD, Schoneveld AH, Moll FL, van Meurs M, Pasterkamp G. Significance of peptidoglycan, a proinflammatory bacterial antigen in atherosclerotic arteries and its association with vulnerable plaques. Am J Cardiol. 2002;90:119-123. (Pubitemid 34775118)
14. Funk CD. Prostaglandins and leukotrienes: advances in eicosanoid biology. Science. 2001;294:1871-1875. (Pubitemid 33101574)
15. Ricciotti E, FitzGerald GA. Prostaglandins and inflammation. Arterioscler Thromb Vasc Biol. 2011;31:986-1000.
16. Haeggström JZ, Funk CD. Lipoxygenase and leukotriene pathways: biochemistry, biology, and roles in disease. Chem Rev. 2011;111:5866-5898.
17. Samuelsson B, Morgenstern R, Jakobsson PJ. Membrane prostaglandin E synthase-1: a novel therapeutic target. Pharmacol Rev. 2007;59:207-224. (Pubitemid 47481434)
18. von Moltke J, Trinidad NJ, Moayeri M, Kintzer AF, Wang SB, van Rooijen N, Brown CR, Krantz BA, Leppla SH, Gronert K, Vance RE. Rapid induction of inflammatory lipid mediators by the inflammasome in vivo. Nature. 2012;490:107-111.
19. Davey MP, Martin TM, Planck SR, Lee J, Zamora D, Rosenbaum JT. Human endothelial cells express NOD2/CARD15 and increase IL-6 secretion in response to muramyl dipeptide. Microvasc Res. 2006;71:103-107.
20. Oh HM, Lee HJ, Seo GS, Choi EY, Kweon SH, Chun CH, Han WC, Lee KM, Lee MS, Choi SC, Jun CD. Induction and localization of NOD2 protein in human endothelial cells. Cell Immunol. 2005;237:37-44.
21. Dayer JM, Beutler B, Cerami A. Cachectin/tumor necrosis factor stimulates collagenase and prostaglandin E2 production by human synovial cells and dermal fibroblasts. J Exp Med. 1985;162:2163-2168. (Pubitemid 16149701)
22. Dayer JM, de Rochemonteix B, Burrus B, Demczuk S, Dinarello CA. Human recombinant interleukin 1 stimulates collagenase and prostaglandin E2 production by human synovial cells. J Clin Invest. 1986;77:645-648. (Pubitemid 16037670)
23. Bäck M, Bu DX, Bränström R, Sheikine Y, Yan ZQ, Hansson GK. Leukotriene B4 signaling through NF-kappaB-dependent BLT1 receptors on vascular smooth muscle cells in atherosclerosis and intimal hyperplasia. Proc Natl Acad Sci USA. 2005;102:17501-17506. (Pubitemid 41740895)
24. Qiu H, Gabrielsen A, Agardh HE, Wan M, Wetterholm A, Wong CH, Hedin U, Swedenborg J, Hansson GK, Samuelsson B, Paulsson-Berne G, Haeggström JZ. Expression of 5-lipoxygenase and leukotriene A4 hydrolase in human atherosclerotic lesions correlates with symptoms of plaque instability. Proc Natl Acad Sci USA. 2006;103:8161-8166. (Pubitemid 43801069)
25. Bäck M, Sultan A, Ovchinnikova O, Hansson GK. 5- Lipoxygenaseactivating protein: a potential link between innate and adaptive immunity in atherosclerosis and adipose tissue inflammation. Circ Res. 2007;100:946-949. (Pubitemid 46598919)
26. Spanbroek R, Grabner R, Lotzer K, et al. Expanding expression of the 5-lipoxygenase pathway within the arterial wall during human atherogenesis. Proc Natl Acad Sci USA. 2003;100:1238-1243. (Pubitemid 36183986)
27. Bresalier RS, Sandler RS, Quan H, Bolognese JA, Oxenius B, Horgan K, Lines C, Riddell R, Morton D, Lanas A, Konstam MA, Baron JA; Adenomatous Polyp Prevention on Vioxx (APPROVe) Trial Investigators. Cardiovascular events associated with rofecoxib in a colorectal adenoma chemoprevention trial. N Engl J Med. 2005;352:1092-1102. (Pubitemid 40365350)
28. Grosser T, Yu Y, Fitzgerald GA. Emotion recollected in tranquility: lessons learned from the COX-2 saga. Annu Rev Med. 2010;61:17-33.
29. Gertow K, Nobili E, Folkersen L, Newman JW, Pedersen TL, Ekstrand J, Swedenborg J, Kühn H, Wheelock CE, Hansson GK, Hedin U, Haeggström JZ, Gabrielsen A. 12-and 15-lipoxygenases in human carotid atherosclerotic lesions: associations with cerebrovascular symptoms. Atherosclerosis. 2011;215:411-416.
30. Cyrus T, Praticò D, Zhao L, Witztum JL, Rader DJ, Rokach J, FitzGerald GA, Funk CD. Absence of 12/15-lipoxygenase expression decreases lipid peroxidation and atherogenesis in apolipoprotein e-deficient mice. Circulation. 2001;103:2277-2282. (Pubitemid 32433718)
31. Huo Y, Zhao L, Hyman MC, et al. Critical role of macrophage 12/15-lipoxygenase for atherosclerosis in apolipoprotein E-deficient mice. Circulation. 2004;110:2024-2031. (Pubitemid 39331917)
32. Viemann D, Goebeler M, Schmid S, Klimmek K, Sorg C, Ludwig S, Roth J. Transcriptional profiling of IKK2/NF-kappa B-and p38 MAP kinasedependent gene expression in TNF-alpha-stimulated primary human endothelial cells. Blood. 2004;103:3365-3373. (Pubitemid 38525666)
33. Lei ZB, Zhang Z, Jing Q, Qin YW, Pei G, Cao BZ, Li XY. OxLDL upregulates CXCR2 expression in monocytes via scavenger receptors and activation of p38 mitogen-activated protein kinase. Cardiovasc Res. 2002;53:524-532. (Pubitemid 34117704)
34. Smith SJ, Fenwick PS, Nicholson AG, Kirschenbaum F, Finney-Hayward TK, Higgins LS, Giembycz MA, Barnes PJ, Donnelly LE. Inhibitory effect of p38 mitogen-activated protein kinase inhibitors on cytokine release from human macrophages. Br J Pharmacol. 2006;149:393-404. (Pubitemid 44582246)
35. Seimon TA, Wang Y, Han S, Senokuchi T, Schrijvers DM, Kuriakose G, Tall AR, Tabas IA. Macrophage deficiency of p38alpha MAPK promotes apoptosis and plaque necrosis in advanced atherosclerotic lesions in mice. J Clin Invest. 2009;119:886-898.
36. Kobayashi K, Inohara N, Hernandez LD, Galán JE, Núñez G, Janeway CA, Medzhitov R, Flavell RA. RICK/Rip2/CARDIAK mediates signalling for receptors of the innate and adaptive immune systems. Nature. 2002;416:194-199. (Pubitemid 34246479)
37. Hsu LC, Ali SR, McGillivray S, Tseng PH, Mariathasan S, Humke EW, Eckmann L, Powell JJ, Nizet V, Dixit VM, Karin M. A NOD2-NALP1 complex mediates caspase-1-dependent IL-1beta secretion in response to Bacillus anthracis infection and muramyl dipeptide. Proc Natl Acad Sci USA. 2008;105:7803-7808. (Pubitemid 351872719)
38. Kikawada E, Bonventre JV, Arm JP. Group V secretory PLA2 regulates TLR2-dependent eicosanoid generation in mouse mast cells through amplification of ERK and cPLA2alpha activation. Blood. 2007;110:561-567. (Pubitemid 47105394)
39. Ruipérez V, Astudillo AM, Balboa MA, Balsinde J. Coordinate regulation of TLR-mediated arachidonic acid mobilization in macrophages by group IVA and group V phospholipase A2s. J Immunol. 2009;182:3877-3883.
40. Poeckel D, Funk CD. The 5-lipoxygenase/leukotriene pathway in preclinical models of cardiovascular disease. Cardiovasc Res. 2010;86:243-253.
41. Funk CD. Leukotriene modifiers as potential therapeutics for cardiovascular disease. Nat Rev Drug Discov. 2005;4:664-672. (Pubitemid 41149760)
42. Di Gennaro A, Wågsäter D, Mäyränpää MI, Gabrielsen A, Swedenborg J, Hamsten A, Samuelsson B, Eriksson P, Haeggström JZ. Increased expression of leukotriene C4 synthase and predominant formation of cysteinylleukotrienes in human abdominal aortic aneurysm. Proc Natl Acad Sci USA. 2010;107:21093-21097.
43. Rådmark O, Werz O, Steinhilber D, Samuelsson B. 5-Lipoxygenase: regulation of expression and enzyme activity. Trends Biochem Sci. 2007;32:332-341. (Pubitemid 47021417)
44. Surette ME, Palmantier R, Gosselin J, Borgeat P. Lipopolysaccharides prime whole human blood and isolated neutrophils for the increased synthesis of 5-lipoxygenase products by enhancing arachidonic acid availability: involvement of the CD14 antigen. J Exp Med. 1993;178:1347-1355. (Pubitemid 23277366)
45. Hattermann K, Picard S, Borgeat M, Leclerc P, Pouliot M, Borgeat P. The Toll-like receptor 7/8-ligand resiquimod (R-848) primes human neutrophils for leukotriene B4, prostaglandin E2 and platelet-activating factor biosynthesis. FASEB J. 2007;21:1575-1585. (Pubitemid 46684859)